# Carb\-X Generated by Yoast SEO v28.2, this is an llms.txt file, meant for consumption by LLMs. ## Pages - [Home](https://carb-x.org/) - [Portfolio Product Developers](https://carb-x.org/portfolio/portfolio-companies/) - [Application Process](https://carb-x.org/apply/application-process/) - [Portfolio\-Pipeline](https://carb-x.org/portfolio/portfolio-pipeline/) - [Management \& Staff](https://carb-x.org/about/management-team/) ## Team - [KEVIN OUTTERSON, ESQ\.](https://carb-x.org/team/kevin-outterson-esq/) - [Sarah Walker](https://carb-x.org/team/sarah-walker/) - [Richard Alm, PHD](https://carb-x.org/team/richard-alm-phd/) - [Nataliya Omelchuk\-Perrin, LL\.M](https://carb-x.org/team/nataliya-omelchuk-perrin-ll-m/) - [Jesse Oakes](https://carb-x.org/team/jesse-oakes/) ## Gallery - [Innoviva Specialty Therapeutics](https://carb-x.org/gallery/innoviva-specialty-therapeutics/) - [University of Maryland](https://carb-x.org/gallery/university-of-maryland/) - [AdJane](https://carb-x.org/gallery/10173/) - [Myers Research Group](https://carb-x.org/gallery/myers-research-group/) - [Tamrisa](https://carb-x.org/gallery/tamrisa/) ## CARB\-X News - [CARB\-X aims to accelerate neonatal sepsis diagnostic development via innovative funding mechanism](https://carb-x.org/carb-x-news/carb-x-aims-to-accelerate-neonatal-sepsis-diagnostic-development-via-innovative-funding-mechanism/) - [Boston University\-led biopharmaceutical accelerator boosts new drugs’ chances of success, study finds](https://carb-x.org/carb-x-news/boston-university-led-biopharmaceutical-accelerator-boosts-new-drugs-chances-of-success-study-finds/) - [A ‘nightmare bacteria’ is surging while investment in antibiotics lags](https://carb-x.org/carb-x-news/a-nightmare-bacteria-is-surging-while-investment-in-antibiotics-lags/) - [Seres Therapeutics announces early clinical data showing potential for SER\-155 in immune checkpoint inhibitor\-related enterocolitis](https://carb-x.org/carb-x-news/seres-therapeutics-announces-early-clinical-data-showing-potential-for-ser-155-in-immune-checkpoint-inhibitor-related-enterocolitis/) - [Using viruses against bacteria: €15 million for phage therapy](https://carb-x.org/carb-x-news/using-viruses-against-bacteria-e15-million-for-phage-therapy/) ## Recommended News - [Solving Antimicrobial Resistance, Vaccines, Antibiotics](https://carb-x.org/recommended_news/solving-antimicrobial-resistance-vaccines-antibiotics/): Antibiotic\-resistant superbugs could become a greater threat than cancer\. Bruno and Pedro at the startup Immunethep explain how they’re tackling the crisis with vaccines\. - [Visby Medical CEO Explains What Makes its PCR Test for Women’s Health Different](https://carb-x.org/recommended_news/visby-medical-ceo-explains-what-makes-its-pcr-test-for-womens-health-different/): Visby Medical CEO explains what makes its PCR test for women’s health different - [What Is the Cost of Underinvesting in Health?](https://carb-x.org/recommended_news/what-is-the-cost-of-underinvesting-in-health/): Every $1 invested in health yields up to $4 in economic return, yet health systems remain chronically underfunded\. From antimicrobial resistance to air pollution, aid cuts and digital health gaps, the cost of inaction is mounting\. What are the societal and economic consequences of underinvesting in health and how do we begin to address them? - [Industry Innovation Series: Frontiers in Infectious Diseases Innovation](https://carb-x.org/recommended_news/industry-innovation-series-frontiers-in-infectious-diseases-innovation/): The final event in the 2025 Industry Innovation Series, ‘Frontiers in Infectious Diseases Innovation,’ offered attendees \- across industry and academia \- a unique opportunity to explore pioneering advances in infectious disease solutions and collaborative opportunities\. Hosted in La Trobe University’s innovation centre, Eagleworks, on the Melbourne Campus, it was an evening of insightful discussion and networking, and highlighted the critical role of innovation in shaping the future of disease prevention and treatment\. - [Leveraging Evidence and Tools to Advance AMR Policy Implementation](https://carb-x.org/recommended_news/leveraging-evidence-and-tools-to-advance-amr-policy-implementation/) ## Venues - [London, UK](https://carb-x.org/venue/london-u-k/) - [Vienna, Austria](https://carb-x.org/venue/vienna-austria/) - [Basel, Switzerland](https://carb-x.org/venue/basel-switzerland/) - [London, UK](https://carb-x.org/venue/london-uk/) - [Tokyo, Japan](https://carb-x.org/venue/tokyo-japan/) ## Organizers - [GAMRIC](https://carb-x.org/organizer/gamric/) - [Financial Times](https://carb-x.org/organizer/financial-times/) - [McMaster University](https://carb-x.org/organizer/mcmaster-university/) - [British Society for Antimicrobial Chemotherapy](https://carb-x.org/organizer/british-society-for-antimicrobial-chemotherapy/) - [Les Pensières Center for Global Health](https://carb-x.org/organizer/les-pensieres-center-for-global-health/) ## Events - [Global AMR Innovators Conference \(GAMRIC\)](https://carb-x.org/event/global-amr-innovators-conference-gamric/) - [World Health Summit 2025](https://carb-x.org/event/world-health-summit-2025/) - [Association for Diagnostics \& Laboratory Medicine 2025](https://carb-x.org/event/association-for-diagnostics-laboratory-medicine-2025/) - [ASM Microbe](https://carb-x.org/event/asm-microbe-2/) - [The 2nd Asia Pacific Conference on Point of Care Testing for Infectious Diseases](https://carb-x.org/event/the-2nd-asia-pacific-conference-on-point-of-care-testing-for-infectious-diseases/) ## Optional - [Sitemap index](https://carb-x.org/sitemap_index.xml)